Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Apr-15 11:58 AM View:  | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 48,006 | $173.00 | $8,305,040.00 | (64%) 74.96K to 26.96K | |
| 03-Apr-15 11:58 AM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition (change in control) | 26,956 | $173.00 | $4,663,390.00 | (100%) 26.96K to 0 | |
| 09-Mar-15 5:01 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 06-Mar-15 | Private Sale | 4,000 | $157.55 | $630,200.00 | (5%) 78.96K to 74.96K | |
| 08-Jan-15 5:01 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Jan-15 | Payment of Exercise | 8,408 | $114.94 | $966,416.00 | (10%) 87.37K to 78.96K | (5%) |
| 26-Aug-14 7:08 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 22-Aug-14 | Grant | 18,559 | $158.30 | $2,937,890.00 | 27% 68.81K to 87.37K | (24%) |
| 03-Jul-14 4:11 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Jul-14 | Payment of Exercise | 1,243 | $123.35 | $153,324.00 | (2%) 70.05K to 68.81K | 3% |
| 20-May-14 4:40 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 16-May-14 | Market Sale | 900 | $105.67 | $95,103.00 | (1%) 70.95K to 70.05K | (14%) |
| 21-Apr-14 5:39 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 17-Apr-14 | Grant | 18,559 | $100.66 | $1,868,150.00 | 35% 52.4K to 70.95K | 19% |
| 06-Mar-14 5:45 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 04-Mar-14 | Market Sale | 1,319 | $110.66 | $145,961.00 | (2%) 53.71K to 52.4K | (9%) |
| 09-Jan-14 4:40 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 07-Jan-14 | Market Sale (Planned) | 8,463 | $88.31 | $747,368.00 | (14%) 62.18K to 53.71K | (36%) |
| 06-Jan-14 4:50 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Jan-14 | Payment of Exercise | 4,547 | $89.94 | $408,957.00 | (7%) 66.72K to 62.18K | (34%) |
| 03-Jul-13 4:47 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Jul-13 | Payment of Exercise | 3,196 | $66.15 | $211,415.00 | (5%) 69.92K to 66.72K | (82%) |
| 22-Apr-13 7:02 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 18-Apr-13 | Grant | 21,354 | $48.70 | $1,039,940.00 | 44% 48.57K to 69.92K | 147% |
| 08-Mar-13 4:54 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 07-Mar-13 | Market Sale | 2,000 | $49.69 | $99,380.00 | (4%) 50.57K to 48.57K | (142%) |
| 08-Mar-13 4:54 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 06-Mar-13 | Market Sale | 5,000 | $49.34 | $246,700.00 | (9%) 55.57K to 50.57K | (144%) |
| 04-Jan-13 4:49 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Jan-13 | Payment of Exercise | 3,149 | $40.47 | $127,440.00 | (5%) 58.72K to 55.57K | (197%) |
| 05-Jul-12 4:24 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Jul-12 | Payment of Exercise | 3,123 | $54.44 | $170,016.00 | (5%) 61.84K to 58.72K | (121%) |
| 27-Apr-12 3:51 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 25-Apr-12 | Grant | 19,406 | -- | -- | 46% 42.43K to 61.84K | |
| 05-Jan-12 4:39 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 03-Jan-12 | Payment of Exercise | 1,040 | $47.85 | $49,764.00 | (2%) 43.47K to 42.43K | (151%) |
| 06-Jul-11 4:55 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Jul-11 | Payment of Exercise | 5,993 | $39.83 | $238,701.00 | (12%) 49.47K to 43.47K | (202%) |